✦ LIBER ✦

Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma

✍ Scribed by Peter Hersey; Scott W. Menzies; Brendon Coventry; Tam Nguyen; Margaret Farrelly; Susan Collins; Debbie Hirst; Heather Johnson

Publisher: Springer-Verlag
Year: 2004
Tongue: English
Weight: 267 KB
Volume: 54
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-004-0587-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II study of treatment with dendr

Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma

✍ Peter Hersey; ScottW. Menzies; GaryM. Halliday; Tam Nguyen; MargaretL. Farrelly; 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 214 KB

Phase I study of intranodal delivery of

Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma

✍ Scott T. Tagawa; Peter Lee; Jolie Snively; William Boswell; Song Ounpraseuth; Sa 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

## Abstract ## BACKGROUND Based on the likelihood of transfecting large numbers of local antigen‐presenting cells, a Phase I study in patients with Stage IV melanoma was conducted to determine the practicality, toxicity of, and immune responses to repeated infusions into a groin lymph node of esca

A phase III randomized, doúble-blind, mu

A phase III randomized, doúble-blind, multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma

✍ Marc K. Wallack; Muthukumaran Sivanandham; Charles M. Balch; Marshall M. Urist; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 876 KB

Telomerase peptide vaccination: a phase

Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer

✍ Paal F. Brunsvig; Steinar Aamdal; Marianne K. Gjertsen; Gunnar Kvalheim; Carrie 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 364 KB

A phase I vaccination study with tyrosin

A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)

✍ Ralf G. Meyer; Cedrik M. Britten; Ulrike Siepmann; Barbara Petzold; Tolga A. Sag 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 495 KB

Survival analysis after resection of met

Survival analysis after resection of metastatic disease followed by peptide vaccines in patients with Stage IV melanoma

✍ Scott T. Tagawa; Eric Cheung; Warren Banta; Conway Gee; Jeffrey S. Weber 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 3 views